South Africa vape tax review urged over nicotine strength incentive
A consumer advocate is asking National Treasury to commission an independent review of South Africa's per-millilitre e-liquid excise, arguing a flat volume charge makes a concentrated 10ml bottle cheaper in duty than a 30ml bottle with the same total nicotine.
Key points
- Kurt Yeo of THR Global asked National Treasury to commission and publish an independent assessment of South Africa's per-millilitre e-liquid duty.
- SARS guidance cited in the article bases the duty on e-liquid volume in millilitres, so a 10ml bottle at 18mg/ml and a 30ml bottle at 6mg/ml carry the same 180mg of nicotine but three times different duty.
- The article states the calculation does not prove consumers switch to stronger products, absorb more nicotine or return to cigarettes.
- Yeo represented THR Global at the Standing Committee on Finance public hearings on 8 October 2024.
- THR Global records 262 participant-reported experiences from 33 countries, which its methodology labels a self-selected sample, not population data.
On this page
Kurt Yeo, founder of THR Global, wants National Treasury to commission and publish an independent assessment of South Africa’s per-millilitre e-liquid excise, arguing the design may reward higher-strength products. He made the call in an article published on 20 November 2026.
The claim rests on arithmetic rather than on sales data. SARS guidance cited in the article bases the duty on the millilitre volume of e-liquid produced, so a flat charge per millilitre scales with bottle size, not with the nicotine inside it.
A 10ml bottle at 18mg/ml carries one-third the duty of 30ml at 6mg/ml
Both hypothetical bottles hold 180mg of nicotine in total. VapeBrief’s calculation, using the article’s flat-per-millilitre assumption: if the charge were R1 per ml, duty would be R10 on the 10ml bottle and R30 on the 30ml bottle for identical nicotine content. The actual SARS rate per millilitre is not stated in the source and is not applied here.
| Bottle | Volume (ml) | Strength (mg/ml) | Total nicotine (mg) | Relative duty at flat per-ml charge |
|---|---|---|---|---|
| Concentrated | 10 | 18 | 180 | 1x |
| Larger, weaker | 30 | 6 | 180 | 3x |
The article itself states the limits of this comparison. A duty differential does not show that consumers switch strength, absorb more nicotine or return to cigarettes. Retail prices also carry manufacturing costs and commercial choices, and nicotine intake depends on how a product is used.
Yeo links the request to a 2024 Parliament appearance
THR Global presented at the Standing Committee on Finance public hearings on proposed revenue legislation on 8 October 2024, with Yeo representing the organisation. The review he now proposes would test retail prices, purchasing patterns and cigarette use, including whether adults change nicotine strength or liquid consumption in response to the duty.
He also proposes examining youth uptake, separating the tax effect from shifts in products, marketing and household finances, and assessing a duty component tied to nicotine content as one option. Any replacement would need testing against the current structure for enforcement and unintended effects, with lower nicotine concentration, lower total nicotine consumption and quitting measured as separate outcomes.
THR Global holds 262 self-selected accounts from 33 countries
The organisation’s platform records 262 participant-reported experiences from 33 countries, describing what people tried and which obstacles they met. Its methodology labels the accounts a self-selected sample rather than population data, so they cannot establish national quit rates, comparative product safety or tax effects.
Yeo argues such testimony shows how adults manage the cost of a quit attempt, and asks for transparent recruitment and disclosure of interests in consumer research, including from people whose attempts failed or who returned to cigarettes.
Cochrane’s August 2026 review covers cessation, not tax design
Cochrane’s living review, updated in August 2026, found high-certainty evidence that nicotine e-cigarettes raise smoking quit rates compared with nicotine replacement therapy such as patches or gum, according to the article. The same review flags uncertainty about adverse effects and calls for longer, larger studies.
Those findings do not establish whether South Africa’s e-liquid duty helps or hinders quitting. The NHS states that vaping is not risk-free, that nicotine is highly addictive and that long-term effects remain uncertain; it advises children and non-smokers against vaping and says adults switching from cigarettes must stop smoking completely to get the full benefits.
Who is affected
Importers, distributors and manufacturers selling into South Africa carry the compliance and pricing question, because a duty set per millilitre falls hardest on larger, lower-strength bottles. Under the analysis above, a brand can hold total nicotine constant and cut its excise exposure by shrinking volume and raising strength. Whether that reshapes shelf mix, order sizes or unit pricing is unproven until purchasing data exists. A nicotine-content-linked duty, if ever adopted, would move compliance work into strength labelling and batch records.
What happens next
The decision rests with National Treasury, which has not committed to the review in the source material. Retailers and distributors tracking cost exposure should watch whether Treasury responds to the request and whether any assessment is published with terms of reference.
Questions readers ask
How does South Africa's e-liquid excise work?
According to SARS guidance cited in the article, the duty is charged on the volume of e-liquid produced, measured in millilitres, rather than on nicotine content. The source does not state the current rate per millilitre.
Has National Treasury agreed to review the tax?
The source does not report any commitment from National Treasury. Kurt Yeo of THR Global is calling for an independent assessment to be commissioned and published.
Sources
18+ only. This site is for adult readers and provides news and information only. It is not medical, legal or purchase advice. Nicotine is addictive. Always check the official text of any regulation in your market. Health Information



